Key result
ATI score accurately predicts post-PCI microvascular impairment in STEMI patients with an AUC of 0.87.
Why the study?
Does the ATI score predict post-procedural microvascular impairment (IMR >40) in STEMI patients undergoing PPCI?
Cohort (n=186)
Yes
Does the ATI score predict post-procedural microvascular impairment (IMR >40) in STEMI patients undergoing PPCI?
Answers are grounded in this paper and cite their sources.
The ATI score is a simple, procedurally derived tool that accurately predicts the risk of post-stenting microvascular impairment in STEMI patients, allowing for early risk stratification during PPCI.
AIMS: Restoration of effective myocardial reperfusion by primary percutaneous coronary intervention (PPCI) in patients with ST-elevation myocardial infarction is difficult to predict. A method to assess the likelihood of a suboptimal response to conventional pharmacomechanical therapies could be beneficial. We aimed to derive and validate a scoring system that can be used acutely at the time of coronary reopening to predict the likelihood of downstream microvascular impairment in patients with STEMI. METHODS AND RESULTS: A score estimating the risk of post-procedural microvascular injury defined by an index of microcirculatory resistance (IMR) >40 was initially derived in a cohort of 85 STEMI patients (derivation cohort). This score was then tested and validated in three further cohorts of patients (retrospective [30 patients], prospective [42 patients] and external [29 patients]). The ATI score (age [>50=1]; pre-stenting IMR [>40 and <100=1; ≥100=2]; thrombus score [4=1; 5=3]) was highly predictive of a post-stenting IMR >40 in all four cohorts (AUC: 0.87; p<0.001-derivation cohort, 0.84; p=0.002-retrospective cohort, 0.92; p<0.001-prospective cohort and 0.81; p=0.006-external cohort). In the whole population, an ATI score ≥4 presented a 95.1% risk of final IMR >40, while no cases of final IMR >40 occurred in the presence of an ATI score <2. CONCLUSIONS: The ATI score appears to be a promising tool capable of identifying patients during PPCI who are at the highest risk of coronary microvascular impairment following revascularisation. This procedural risk stratification has a number of potential research and clinical applications and warrants further investigation.
No takes yet. Share an insight, caveat, or question.
Maria et al. (2016) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=186). ATI score (Age, Thrombus score, pre-stenting IMR) was evaluated on Prediction of post-stenting index of microcirculatory resistance (IMR) >40 (AUC 0.87, 95% CI 0.82-0.92, p=<0.001). The ATI score accurately predicted post-stenting microvascular impairment (IMR >40) in STEMI patients undergoing primary percutaneous coronary intervention, with an AUC of 0.87.
Synapse has enriched 10 related papers. Consider them for comparative context: